Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

FMCG stocks among the top gainers
Thu, 16 Oct 11:30 am

After opening flat, the Indian Indices have struggled to find any direction during the morning trading session. FMCG stocks are witnessing the maximum buying interest while consumer durables and metal stocks are trading in the red.

The BSE-Sensex is trading down 10 points. The NSE-Nifty is trading down 5 points. The BSE Mid Cap index is trading down 0.1% and the BSE Small Cap index is trading down 0.3%%. The rupee is trading at 61.47 to the US dollar.

MNC pharma companies are trading mixed with Abbott India leading the gainers and Novartis India being among the leading losers in the pack. As per the financial daily, the drug pricing regulator has demanded penalty of Rs 3 bn on Novartis India for overcharging consumers on the sale of its leading selling brand Voveran. The said drug is indicated for pain. However as per the reports, the company did not confirm the quantum of the total penalty by the drug regulator, termed the notice as "erroneous and entirely misconceived". In its recent press release the company will be challenging both the basis of the demand as well as the entire quantum of the demand. Reportedly, according to IMS Health annual data, Voveran, has annual sales of about Rs 2.2 bn, and is among the top 10 brands in the domestic drug market. While Novartis has already filled the petition in Delhi high court, any negative verdict can hamper the profits of this company given the pharma companies already facing various challenges.

Telecom stocks are trading mixed today. While Reliance Communications is leading the gainers; Tata Communications is among the top losers. As per a leading financial daily, the telecom commission has cleared the way for pan-India full mobile number portability (MNP). The telecom commission is the highest decision making body in the Department of Telecom (DoT). The measure is to be implemented by 31 March 2015. This will clear the way for a simplified experience for consumers. This will allow users to keep the same number when they change circles or their operators. MNP is currently available within the same circle only. This move can be expected to benefit incumbents like Bharti Airtel, Vodafone and Idea Cellular in the long term.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "FMCG stocks among the top gainers". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.